GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress May 11, 2023 07:00AM
GreenLight Biosciences Releases Inaugural Sustainability Report Apr 12, 2023 06:59AM
GreenLight Biosciences Releases Inaugural Sustainability Report Apr 12, 2023 06:59AM
GreenLight Biosciences Holdings (GRNA) Confirms Receipt of Indication of Interest from Fall Line Mar 30, 2023 04:06PM
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line Mar 30, 2023 04:05PM


Mar 30, 2023 04:05PM GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
Mar 28, 2023 05:05PM GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
Mar 28, 2023 05:05PM GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
Mar 9, 2023 06:59AM GreenLight Biosciences (GRNA) Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
Mar 9, 2023 06:59AM GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
Mar 9, 2023 06:59AM GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
Mar 7, 2023 07:06AM GreenLight Biosciences (GRNA) Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
Mar 7, 2023 06:59AM GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
Mar 7, 2023 06:59AM GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
Mar 1, 2023 06:24AM GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
Mar 1, 2023 06:24AM GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
Feb 1, 2023 07:24AM GreenLight Biosciences Holdings (GRNA) Approved to Initiate Phase I/II trial of Covid-19 mRNA Vaccine
Feb 1, 2023 07:20AM GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Feb 1, 2023 07:20AM GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Jan 9, 2023 07:21AM GreenLight Biosciences (GRNA) and Epivax Enter Collaboration Agreement to Develop Personalized Cancer Vaccines
Jan 9, 2023 07:20AM GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
Jan 9, 2023 07:20AM GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
Nov 9, 2022 05:07PM GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
Nov 9, 2022 05:07PM GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
Nov 7, 2022 11:25AM GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
Nov 7, 2022 11:25AM GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
Oct 12, 2022 06:55AM GreenLight Biosciences Holdings (GRNA) Announces 25% Stuff Cut, Will Focus on Near-Term Value Drivers
Oct 12, 2022 06:54AM GreenLight Biosciences announces realignment to focus on near-term value drivers
Oct 12, 2022 06:54AM GreenLight Biosciences announces realignment to focus on near-term value drivers